Publications
Publishing the Frontiers of Immuno-Oncology
Spotlight Publication
Botensilimab (Fc-enhanced anti-CTLA-4), Balstilimab (PD-1 inhibitor)
Emerging survival plateaus with botensilimab and balstilimab: Pan tumor data from a large phase 1b trial of advanced solid tumors
Oct 17, 2025
,
Gordon et al.
ESMO
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
QS-21 STIMULON™ Adjuvant
A Heat Shock Protein Based Polyvalent Vaccine Targeting HSV-2: CD4(+) and CD8(+) Cellular Immunity and Protective Efficacy.
Other Articles & Publications
Vaccine
June 2, 2022
,
Mo, et al.
No items found.
QS-21 STIMULON™ Adjuvant
Safety and Efficacy of the RTS,S/AS01E Candidate Malaria Vaccine Given With Expanded-Programme-On-Immunisation Vaccines: 19 Month Follow-Up of a Randomised, Open-Label, Phase 2 Trial.
Other Articles & Publications
The Lancet Infectious Diseases
June 2, 2022
,
Asante, et al.
No items found.
QS-21 STIMULON™ Adjuvant
Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants.
Other Articles & Publications
New England Journal of Medicine
June 2, 2022
,
Abdulla, et al.
No items found.
QS-21 STIMULON™ Adjuvant
Rapid, Enhanced, and Persistent Protection of Patients with Renal Insufficiency by AS02(V)-Adjuvanted Hepatitis B Vaccine.
Other Articles & Publications
Kidney International
June 2, 2022
,
Surquin, et al.
No items found.